Improved Quality of Stroke Care for Hospitalized Medicare Beneficiaries in Michigan

Department of Neurology, Wayne State University School of Medicine, Detroit, Michigan, USA.
Stroke (Impact Factor: 5.72). 06/2005; 36(6):1227-31. DOI: 10.1161/01.STR.0000166026.14624.29
Source: PubMed


We reported previously that acute ischemic stroke patients encountered delays in obtaining neuroimaging and receiving thrombolysis, and that deep venous thrombosis prophylaxis was used only in a minority of eligible patients. We investigated whether these and other measures improved after a quality improvement initiative.
Medicare fee-for-service ischemic stroke and transient ischemic attack discharges in 136 acute care hospitals in Michigan were identified by International Classification of Diseases, 9th Revision, Clinical Modification codes. Only patients with stroke symptoms persisting for >1 hour and present on arrival were included in the analysis. Seven quality indicators were abstracted from chart review at baseline (discharges between July 1, 1998, and June 30, 1999) and at remeasurement (discharges between January 1, 2001, and June 30, 2001) after an intensive quality improvement initiative throughout Michigan hospitals. Quality indicators were compared at baseline and remeasurement.
Indicators of care were determined in 5146 patients at baseline and 4980 patients on remeasurement. Four quality-of-care indicators showed significant improvement on remeasurement: antithrombotic prescribed at discharge (81.9 baseline versus 83.7% remeasurement; P=0.026), avoidance of sublingual nifedipine in patients with acute ischemic stroke (97.1 versus 99.7%; P<0.0001), documentation of a computed tomography (CT)/MRI during hospitalization (98.0 versus 99.1%; P=0.024), and appropriate deep venous thrombosis prophylaxis (13.8 versus 26.9%; P<0.0001). Time to CT/MRI did not significantly change, but time to thrombolysis improved (113 versus 88.5 minutes; P=0.045).
Improvement occurred in several indicators of quality of care in Michigan Medicare beneficiaries presenting with acute stroke symptoms.

Download full-text

Full-text preview

Available from:
  • [Show abstract] [Hide abstract]
    ABSTRACT: Michigan's prototype of the Paul Coverdell National Acute Stroke Registry revealed improvement opportunities in acute stroke care. A partnership among the registry investigators, American Stroke Association (ASA), Michigan Department of Community Health, and 13 Michigan hospitals was implemented in 2004. The Institute for Healthcare Improvement Breakthrough Series model and the ASA's Get With The Guidelines-Stroke program and Patient Management Tool (PMT) were used to implement tailored stroke practice guidelines at each hospital. Significant improvements (p < .05) were observed for 5 of the 16 measures. Smoking cessation increased by 31%, dysphagia screening increased by 19%, use of the NIH stroke scale increased by 19%, documentation of reasons for not using recombinant tissue plasminogen activator (rt-PA) increased 13%, and documentation of dyslipidemia increased by 9%. Clinically and statistically significant improvements can be made in acute stroke care using a collaborative and systematic approach to QI that employs protocol utilization and ongoing data collection and review as part of an organized PMT.
    Joint Commission journal on quality and patient safety / Joint Commission Resources 09/2006; 32(9):517-27.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Our goal is to provide an overview of the current evidence about components of the evaluation and treatment of adults with acute ischemic stroke. The intended audience is physicians and other emergency healthcare providers who treat patients within the first 48 hours after stroke. In addition, information for healthcare policy makers is included. Members of the panel were appointed by the American Heart Association Stroke Council's Scientific Statement Oversight Committee and represented different areas of expertise. The panel reviewed the relevant literature with an emphasis on reports published since 2003 and used the American Heart Association Stroke Council's Levels of Evidence grading algorithm to rate the evidence and to make recommendations. After approval of the statement by the panel, it underwent peer review and approval by the American Heart Association Science Advisory and Coordinating Committee. It is intended that this guideline be fully updated in 3 years. Management of patients with acute ischemic stroke remains multifaceted and includes several aspects of care that have not been tested in clinical trials. This statement includes recommendations for management from the first contact by emergency medical services personnel through initial admission to the hospital. Intravenous administration of recombinant tissue plasminogen activator remains the most beneficial proven intervention for emergency treatment of stroke. Several interventions, including intra-arterial administration of thrombolytic agents and mechanical interventions, show promise. Because many of the recommendations are based on limited data, additional research on treatment of acute ischemic stroke is needed.
    Circulation 06/2007; 115(20):e478-534. DOI:10.1161/CIRCULATIONAHA.107.181486 · 14.43 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Adherence to evidence-based interventions for hospitalized patients who have experienced a stroke is suboptimal. We examined the association of process improvement and Internet-based data collection and decision support with stroke care. A 1-year intervention study to assess performance measure adherence in hospitals using the "Get With The Guidelines-Stroke" program. The program included 18 410 patients with ischemic stroke or transient ischemic attack admitted to 99 volunteer community and teaching hospitals. Data from eligible patients in the preintervention baseline period were compared with data from 4 subsequent quarters for 12 acute care or secondary prevention measures and an all-or-none measure of care based on 7 prespecified measures. Significant improvements from baseline to the fourth quarter were seen in 11 of 13 measures: use of thrombolytic medications for patients with ischemic stroke presenting within 2 hours of onset, 23.5% vs 40.8% (P < .001); early use of antithrombotic medications, 88.2% vs 95.2% (P < .001); antithrombotic medications prescribed at discharge, 91.0% vs 97.9% (P < .001); anticoagulation agents for atrial fibrillation, 81.4% vs 96.5% (P < .001); smoking cessation counseling, 38.3% vs 54.5% (P < .001); lipid treatment for low-density lipoprotein levels 100 mg/dL or greater, 58.7% vs 77.0% (P < .001); diabetes mellitus treatment, 48.5% vs 83.5% (P = .001); and weight reduction counseling 32.5% vs 43.4% (P < .001). The all-or-none measure increased from 50.2% to 58.0% (P < .001). Complications from thrombolytic medications and prophylaxis for deep venous thrombosis did not change. Statistically and clinically significant improvement in 11 of 13 quality improvement measures for the treatment of patients hospitalized for cerebrovascular disease was seen in hospitals participating in the Get With The Guidelines program.
    Archives of Internal Medicine 03/2008; 168(4):411-7. DOI:10.1001/archinternmed.2007.101 · 17.33 Impact Factor
Show more